• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Establishment of therapeutic strategy for advanced gastrointestinal cancer with targeted alpha therapy

Research Project

Project/Area Number 16H02668
Research Category

Grant-in-Aid for Scientific Research (A)

Allocation TypeSingle-year Grants
Section一般
Research Field Radiation science
Research InstitutionKanazawa University

Principal Investigator

Kinuya Seigo  金沢大学, 医学系, 教授 (20281024)

Co-Investigator(Kenkyū-buntansha) 久保 均  福島県立医科大学, 公私立大学の部局等, 教授 (00325292)
萱野 大樹  金沢大学, 附属病院, 助教 (10547152)
伊藤 浩  福島県立医科大学, 公私立大学の部局等, 教授 (20360357)
小川 数馬  金沢大学, 新学術創成研究機構, 准教授 (30347471)
村山 敏典  金沢大学, 附属病院, 教授 (30378765)
吉村 健一  金沢大学, 附属病院, 特任教授 (30415517)
稲野 彰洋  福島県立医科大学, 医学部, 准教授 (30437933)
織内 昇  福島県立医科大学, 公私立大学の部局等, 教授 (40292586)
若林 大志  金沢大学, 附属病院, 助教 (60622818)
今井 康人  金沢大学, 附属病院, 特任教授 (60720878)
鷲山 幸信  福島県立医科大学, 公私立大学の部局等, 准教授 (80313675)
栗林 義和  金沢大学, 附属病院, 特任教授 (40756186)
富永 英之  福島県立医科大学, 公私立大学の部局等, 准教授 (00393348)
稲木 杏吏  金沢大学, 医学系, 助教 (40645131)
Project Period (FY) 2016-04-01 – 2019-03-31
Project Status Completed (Fiscal Year 2018)
Budget Amount *help
¥42,380,000 (Direct Cost: ¥32,600,000、Indirect Cost: ¥9,780,000)
Fiscal Year 2018: ¥16,510,000 (Direct Cost: ¥12,700,000、Indirect Cost: ¥3,810,000)
Fiscal Year 2017: ¥15,990,000 (Direct Cost: ¥12,300,000、Indirect Cost: ¥3,690,000)
Fiscal Year 2016: ¥9,880,000 (Direct Cost: ¥7,600,000、Indirect Cost: ¥2,280,000)
Keywords核医学治療 / 内用療法 / 内照射療法 / α線 / 標識合成 / 消化器癌 / 放射線管理 / 大腸癌 / 内科 / 内照射
Outline of Final Research Achievements

Preclinical study regarding development of highly effective alpha targeted radiotherapy was performed with 211At. Sufficient amount of 211At could be obtained for clinical application after the optimization of irradiation parameters and conditions of cyclotron. Cyclic RGD peptide against αVβ3 integrin was effectively labeled with 211At as [211At]c[RGDf(4-At)K] at high yield. This radio-compound specifically attached the target molecules and accumulated into tumor xenografts.For imaging, drug design using DOTA as a chelating agent was conducted. Information of radiation protection,regulatory science for the future clinical application was obtained. In addition, platform to obtain clinical POC has been established. The progress in 211At medical usage was reported at several domestic and international conferences.

Academic Significance and Societal Importance of the Research Achievements

多くの癌腫で進行癌に対する効果的な治療法は確立されていない。一方近年、進展した前立腺癌患者においてα線核種核医学治療で寛解を得られるまでに奏功している事例が報告されており、他癌腫においても同様の展開が期待されるところである。本研究では、多くの癌腫で発現するαVβ3インテグリンを標的とした検討した結果、[211At]c[RGDf(4-At)K]を得ることができた。サイクロトロンで臨床応用可能な211At生成が可能であることが示され、臨床応用のための法的議論が深まったことにより、国内開発されたα線核種核医学治療を世界に発信できる可能性が見られた事により、将来患者利益に繋がることが期待される。

Report

(4 results)
  • 2018 Annual Research Report   Final Research Report ( PDF )
  • 2017 Annual Research Report
  • 2016 Annual Research Report
  • Research Products

    (69 results)

All 2019 2018 2017 2016

All Journal Article (18 results) (of which Int'l Joint Research: 1 results,  Peer Reviewed: 17 results,  Open Access: 13 results) Presentation (51 results) (of which Int'l Joint Research: 16 results,  Invited: 15 results)

  • [Journal Article] Radiotheranostics Coupled between an At-211-Labeled RGD Peptide and the Corresponding Radioiodine-Labeled RGD Peptide2019

    • Author(s)
      Ogawa Kazuma、Takeda Takuya、Mishiro Kenji、Toyoshima Atsushi、Shiba Kazuhiro、Yoshimura Takashi、Shinohara Atsushi、Kinuya Seigo、Odani Akira
    • Journal Title

      ACS Omega

      Volume: 4 Issue: 3 Pages: 4584-4591

    • DOI

      10.1021/acsomega.8b03679

    • NAID

      120007185656

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Syntheses and evaluation of a homologous series of aza-vesamicol as improved radioiodine-labeled probes for sigma-1 receptor imaging2019

    • Author(s)
      Ogawa Kazuma、Masuda Ryohei、Mishiro Kenji、Wang Mengfei、Kozaka Takashi、Shiba Kazuhiro、Kinuya Seigo、Odani Akira
    • Journal Title

      Bioorganic & Medicinal Chemistry

      Volume: 18 Issue: 10 Pages: 31998-31999

    • DOI

      10.1016/j.bmc.2019.03.054

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases2019

    • Author(s)
      Uemura Hirotsugu、Uemura Hiroji、Nagamori Satsohi、Wakumoto Yoshiaki、Kimura Go、Kikukawa Hiroaki、Yokomizo Akira、Mizokami Atsushi、Kosaka Takeo、Masumori Naoya、Kawasaki Yoshihide、Yonese Junji、Nasu Yasutomo、Fukasawa Satoshi、Sugiyama Takayuki、Kinuya Seigo、et al
    • Journal Title

      International Journal of Clinical Oncology

      Volume: 24 Issue: 5 Pages: 557-566

    • DOI

      10.1007/s10147-018-01389-4

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Fundamental study of radiogallium-labeled aspartic acid peptides introducing octreotate derivatives2019

    • Author(s)
      Ishizaki Atsushi、Mishiro Kenji、Shiba Kazuhiro、Hanaoka Hirofumi、Kinuya Seigo、Odani Akira、Ogawa Kazuma
    • Journal Title

      Annals of Nuclear Medicine

      Volume: 33 Issue: 4 Pages: 244-251

    • DOI

      10.1007/s12149-018-01326-5

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Design, synthesis, and biological evaluation of radioiodinated benzo[d]imidazole-quinoline derivatives for platelet-derived growth factor receptor β (PDGFRβ) imaging2019

    • Author(s)
      Effendi Nurmaya、Mishiro Kenji、Takarada Takeshi、Yamada Daisuke、Nishii Ryuichi、Shiba Kazuhiro、Kinuya Seigo、Odani Akira、Ogawa Kazuma
    • Journal Title

      Bioorganic & Medicinal Chemistry

      Volume: 27 Issue: 2 Pages: 383-393

    • DOI

      10.1016/j.bmc.2018.12.016

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Introduction of the targeted alpha therapy (with Radium-223) into clinical practice in Japan: learnings and implementation2019

    • Author(s)
      Hosono M, Ikebuchi H, Nakamura Y, Yanagida S, Kinuya S.
    • Journal Title

      Ann Nucl Med

      Volume: 33 Issue: 3 Pages: 211-221

    • DOI

      10.1007/s12149-018-1317-1

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Development of novel diagnostic system for pancreatic cancer, including early stages, measuring mRNA of whole blood cells2019

    • Author(s)
      Sakai Yoshio、Honda Masao、Matsui Shigeyuki、Komori Osamu、Murayama Toshinori、Fujiwara Tadami、Mizuno Masaaki、Imai Yasuhito、Yoshimura Kenichi、Nasti Alessandro、Wada Takashi、Iida Noriho、Kitahara Masaaki、Horii Rika、Toshikatsu Tamai、Nishikawa Masashi、Okafuji Hirofumi、Mizukoshi Eishiro、et al
    • Journal Title

      Cancer Science

      Volume: 110 Issue: 4 Pages: 1364-1388

    • DOI

      10.1111/cas.13971

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Imaging Somatostatin Receptor Activity in Neuroendocrine-differentiated Prostate Cancer2018

    • Author(s)
      Mori Hiroshi、Nakajima Kenichi、Kadomoto Suguru、Mizokami Atsushi、Ikeda Hiroko、Wakabayashi Hiroshi、Kinuya Seigo
    • Journal Title

      Internal Medicine

      Volume: 57 Issue: 21 Pages: 3123-3128

    • DOI

      10.2169/internalmedicine.0630-17

    • ISSN
      0918-2918, 1349-7235
    • Year and Date
      2018-11-01
    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Comparison of Radioiodine- or Radiobromine-Labeled RGD Peptides between Direct and Indirect Labeling Methods2018

    • Author(s)
      Ogawa Kazuma、Takeda Takuya、Yokokawa Masaru、Yu Jing、Makino Akira、Kiyono Yasushi、Shiba Kazuhiro、Kinuya Seigo、Odani Akira
    • Journal Title

      Chemical and Pharmaceutical Bulletin

      Volume: 66 Issue: 6 Pages: 651-659

    • DOI

      10.1248/cpb.c18-00081

    • NAID

      130007382329

    • ISSN
      0009-2363, 1347-5223
    • Year and Date
      2018-06-01
    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Activities for the Development of Targeted Radionuclide Therapy in Japan2018

    • Author(s)
      Kinuya Seigo
    • Journal Title

      Nuclear Medicine and Molecular Imaging

      Volume: 53 Issue: 1 Pages: 35-37

    • DOI

      10.1007/s13139-018-0563-4

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Current Consensus on I-131 MIBG Therapy2018

    • Author(s)
      Kayano Daiki、Kinuya Seigo
    • Journal Title

      Nuclear Medicine and Molecular Imaging

      Volume: 52 Issue: 4 Pages: 254-265

    • DOI

      10.1007/s13139-018-0523-z

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Feasibility of High-dose Iodine-131-metaiodobenzylguanidine Therapy for High-risk Neuroblastoma Preceding Myeloablative Chemotherapy and Hematopoietic Stem Cell Transplantation: a Study Protocol.2018

    • Author(s)
      Araki R, Nishimura R, Inaki A, Wakabayashi H, Imai Y, Kuribayashi Y, Yoshimura K, Murayama T, Kinuya S
    • Journal Title

      Asia Oceania Journal of Nuclear Medicine and Biology

      Volume: 6 Pages: 161-166

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Manual on the proper use of lutetium-177-labeled somatostatin analogue (Lu-177-DOTA-TATE) injectable in radionuclide therapy (2nd ed.)2018

    • Author(s)
      Hosono M, Ikebuchi H, Nakamura Y, Nakamura N, Yamada T, Yanagida S, Kitaoka A, Kojima K, Sugano H, Kinuya S, Inoue T, Hatazawa J.
    • Journal Title

      Ann Nucl Med

      Volume: 32 Issue: 3 Pages: 217-235

    • DOI

      10.1007/s12149-018-1230-7

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] 抗がん剤のジェネリック医薬品の普及状況2018

    • Author(s)
      杉本修治, 今井康人, 飯島肇, 花田和彦, 菅野彩夏, 高橋みのり
    • Journal Title

      臨床医薬

      Volume: 34 Pages: 849-853

    • Related Report
      2018 Annual Research Report
  • [Journal Article] 1.The pharmacological properties of 3-arm or 4-arm DOTA constructs for conjugation to α-melanocyte-stimulating hormone analogues for melanoma imaging2018

    • Author(s)
      Kobayashi M, Kato T, Washiyama K, Ihara M, Mizutani A, Nishi K, Flores LG 2nd, Nishii R, Kawai K.
    • Journal Title

      PLoS One

      Volume: 14 Issue: 3 Pages: e0213397-e0213397

    • DOI

      10.1371/journal.pone.0213397

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Reduction of 223Ra retention in the Large Intestine during Targeted Alpha Therapy with 223RaCl2 by Oral BaSO4 Administration in Mice2018

    • Author(s)
      Hanadatea S, Yoshii Y, Washiyama K, Yoshimoto M, Yamamura T, Watanabe M, Matsumoto H, Igarashi M, Tsuji B A, Higashi T
    • Journal Title

      International Journal of Sciences: Basic and Applied Research

      Volume: 42 Pages: 95-102

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] The Imaging and Dosimetry for Targeted Ra-223 Treatment for Metastatic Castration-Resistant Prostate Cancer.2018

    • Author(s)
      Matsuo S, Mizokami A, Wakabayashi H, Nakajima K, Kudo T and Kinuya S.
    • Journal Title

      Austin J Nucl Med Radiother

      Volume: 5 Pages: 1024-2015

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Comparison of radioiodine- or radiobromine-labeled RGD peptides between direct and indirect labeling methods.2018

    • Author(s)
      K. Ogawa, T. Takeda, M. Yokokawa, J. Yu, A. Makino, Y. Kiyono, K. Shiba, S. Kinuya, A. Odani.
    • Journal Title

      Chem Pharm Bull

      Volume: 印刷中

    • NAID

      130007382329

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed
  • [Presentation] Precision Nuclear Medicine2019

    • Author(s)
      絹谷清剛
    • Organizer
      第70回栃木県核医学研修会
    • Related Report
      2018 Annual Research Report
    • Invited
  • [Presentation] Theranostics in Japan and current status of Fukushima Medical University2019

    • Author(s)
      Oriuchi N
    • Organizer
      Theranostics World Congress 2019
    • Related Report
      2018 Annual Research Report
    • Int'l Joint Research
  • [Presentation] 短寿命α線放出核種を利用した最新がん治療2019

    • Author(s)
      萱野大樹
    • Organizer
      北陸原子力懇談会第41回放射線取扱技術研修会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 有効射程100μmの核弾頭を用いDDS,2019

    • Author(s)
      鷲山幸信
    • Organizer
      理研シンポジウム エンジニアネットワーク・ワークショップ
    • Related Report
      2018 Annual Research Report
  • [Presentation] 遠隔操作可能な合成装置を用いた[211At]MABGの合成とその品質評価2019

    • Author(s)
      粟生木美穂, 峯岸克之, 西嶋剣一, 鈴木寿, 佐々木茂範, 鷲山幸信, 趙松吉, 永津弘太郎, 張明栄, 高橋和弘
    • Organizer
      日本薬学会第139年会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 核医学治療のポテンシャル2018

    • Author(s)
      絹谷清剛
    • Organizer
      和歌山県立医科大学腫瘍センターセミナー
    • Related Report
      2018 Annual Research Report
    • Invited
  • [Presentation] 核医学治療ーprecision nuclear medicine2018

    • Author(s)
      絹谷清剛
    • Organizer
      第1回阪神核医学講演会
    • Related Report
      2018 Annual Research Report
    • Invited
  • [Presentation] 核医学治療推進のために2018

    • Author(s)
      絹谷清剛
    • Organizer
      第31回日本放射線腫瘍学会学術大会
    • Related Report
      2018 Annual Research Report
    • Invited
  • [Presentation] がんと闘うもう一本の矢2018

    • Author(s)
      絹谷清剛
    • Organizer
      北國健康生きがい支援事業 次世代の放射線治療ー陽子線治療と核医学治療
    • Related Report
      2018 Annual Research Report
    • Invited
  • [Presentation] 放射免疫療法(radioimmunotherapy)の意義と将来2018

    • Author(s)
      絹谷清剛
    • Organizer
      RIT Conference 2018
    • Related Report
      2018 Annual Research Report
    • Invited
  • [Presentation] Theranostics in Japan2018

    • Author(s)
      Seigo Kinuya
    • Organizer
      Theranostics World Congress 2019
    • Related Report
      2018 Annual Research Report
    • Int'l Joint Research / Invited
  • [Presentation] Benefit/Risk estimation and radiological protection in special groups2018

    • Author(s)
      Seigo Kinuya
    • Organizer
      12th Congress of the World Federation of Nuclear Medicine and Biology
    • Related Report
      2018 Annual Research Report
    • Int'l Joint Research / Invited
  • [Presentation] 金沢大学附属病院の研究者主導臨床研究における重篤な有害事象報告の記載に関する現状と対応2018

    • Author(s)
      堀川 尚嗣, 長瀬 克彦, 今井 康人, 杉本 修治, 横井 祐子, 野口 栄子, 水上 真喜, 村山 敏典
    • Organizer
      第19回日本臨床試験学会学術集会
    • Related Report
      2018 Annual Research Report
  • [Presentation] Targeted Alpha Therapy in Japan - Where we are in 20182018

    • Author(s)
      Oriuchi N, Washiyama K, Nishijima K, Aoki M, Zhao S, Ukon N, Takahashi K
    • Organizer
      Congress of European Association of Nuclear Medicine
    • Related Report
      2018 Annual Research Report
    • Int'l Joint Research
  • [Presentation] α線放出核種によるがん治療の進歩と国内における研究開発2018

    • Author(s)
      織内 昇
    • Organizer
      第31回日本放射線腫瘍学会総会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 正常マウスにおけるフリー211Atおよびmeta-[211At]astatobenzylguanidine (MABG)の組織吸収線量2018

    • Author(s)
      右近直之、織内 昇、他
    • Organizer
      第58回日本核医学会総会 2018年11月16日
    • Related Report
      2018 Annual Research Report
  • [Presentation] At-211標識RGDペプチドの作製と基礎的検討2018

    • Author(s)
      小川 数馬, 武田 拓也, 三代 憲司, 越後 拓亮, 吉村 崇, 篠原 厚, 柴 和弘, 絹谷 清剛, 小谷 明
    • Organizer
      13回日本分子イメージング学会
    • Related Report
      2018 Annual Research Report
  • [Presentation] Preparation and basic evaluation of an At-211-labeled peptide for targeted alpha therapy2018

    • Author(s)
      K. Ogawa, T. Takeda, K. Mishiro, A. Toyoshima, K. Shiba, T. Yoshimura, A. Shinohara, S. Kinuya, A. Odani
    • Organizer
      12th Congress of the World Federation of Nuclear Medicine and Biology
    • Related Report
      2018 Annual Research Report
    • Int'l Joint Research
  • [Presentation] At211によるα線治療、RITの可能性2018

    • Author(s)
      稲野彰洋
    • Organizer
      ゲノム創薬・医療フォーラム
    • Related Report
      2018 Annual Research Report
  • [Presentation] Prognostic values of high-dose I-131 MIBG therapy in patients with high-risk neuroblastoma2018

    • Author(s)
      Kayano D, Wakabayashi H, Toratani A, Mori H, Akatani N, Yamase T, Watanabe S, Takata A, Hiromasa T, Kinuya S
    • Organizer
      12th Congress of the World Federation of Nuclear Medicine and Biology
    • Related Report
      2018 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Efforts for Certification of the Institutional Ethics Committee in Kanazawa University Hospital, Japan2018

    • Author(s)
      Murayama T
    • Organizer
      The DIA EUROPE 2018
    • Related Report
      2018 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Advanced Clinical Research Center of Fukushima Medical University: two cyclotrons installed facility for basic research and clinical application of medical radioisotopes2018

    • Author(s)
      Takahashi K, Tominaga H, Washiyama K, Nishijima K, Aoki M, Zhao S, Ukon N, Oriuchi N
    • Organizer
      17th International Workshop on Targetry and Target Chemistry
    • Related Report
      2018 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Initial Experiences on the Production of Astatine‐211 at Fukushima Medical University using “CYPRIS MP-30” Cyclotron2018

    • Author(s)
      Oda T, Washiyama K, Aoki M, Taniguchi M, Kato J, Gomez FG, Ishizuka T, Takahashi K
    • Organizer
      17th International Workshop on Targetry and Target Chemistry
    • Related Report
      2018 Annual Research Report
    • Int'l Joint Research
  • [Presentation] ラドンガス密封シリンジを利用したRn-At ジェネレーターシステムの開発2018

    • Author(s)
      川﨑康平, 新 裕喜, 青井景都, 鷲山幸信, 西中一朗,羽場宏光, 矢納慎也, 横山明彦
    • Organizer
      第62回放射化学討論会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 中型サイクロトロンを用いた211At の製造と化学分離2018

    • Author(s)
      鷲山幸信, 粟生木美穂, 佐々木茂範, 小田敬, 西嶋剣一, 高橋和弘
    • Organizer
      第62回放射化学討論会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 211Rn-211At ジェネレーター開発のためのアスタチン溶媒抽出の研究 ―131I との抽出挙動の比較及び酸化剤の効果の調査2018

    • Author(s)
      新裕喜,川崎康平,青井景都,横山明彦,鷲山幸信, 西中一朗,矢納慎也,羽場宏光
    • Organizer
      第62回放射化学討論会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 短寿命α線核種の合理的規制のためのデータ取得による安全性検証と安全管理・教育方法の開発2018

    • Author(s)
      篠原厚, 吉村崇, 豊嶋厚史, 兼田加珠子, 張子見, 永田光知郎, 渡部直史, 大江一弘, 畑澤順, 山村朝雄, 白崎謙次, 菊永英寿, 羽場宏光, 鷲山幸信
    • Organizer
      第62回放射化学討論会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 垂直照射法を用いた211Atの製造に関する諸条件の検討2018

    • Author(s)
      鷲山幸信, 小田敬, 佐々木茂範, 粟生木美穂
    • Organizer
      第58回日本核医学会学術総会
    • Related Report
      2018 Annual Research Report
  • [Presentation] Astatine-211の乾式分離法の検討2018

    • Author(s)
      鷲山幸信, 小田敬, 粟生木美穂, 佐々木茂範, 西嶋剣一,高橋和弘
    • Organizer
      第58回日本核医学会学術総会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 正常マウスにおけるフリー211Atおよびmeta-[211At]astaobenzylguanidine (MABG)の体内動態2018

    • Author(s)
      趙松吉, 粟生木美穂, 鷲山幸信, 右近直之, 譚成博, 下山彩希, 久保均, 織内昇, 高橋和宏, 伊藤浩, 竹之下誠一
    • Organizer
      第58回日本核医学会学術総会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 225Ac/213Biと211Atの核薬学研究の最先端2018

    • Author(s)
      鷲山幸信
    • Organizer
      第58回日本核医学会学術総会
    • Related Report
      2018 Annual Research Report
    • Invited
  • [Presentation] 飼育ケージ内でのAt-211溶液の飛散の空間分布の評価2018

    • Author(s)
      久保均, 右近直之, 下山彩希, 趙松吉, 伊藤浩, 高橋和宏, 粟生木美穂, 鷲山幸信, 西嶋剣一, 佐々木茂範, 矢吹省司
    • Organizer
      第58回日本核医学会学術総会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 正常マウスにおけるフリー211Atおよびmeta-[211At]astaobenzylguanidine (MABG)の組織吸収線量評価2018

    • Author(s)
      右近直之, 鷲山幸信, 趙松吉, 織内昇, 粟生木美穂, 譚成博, 下山彩希, 久保均, 高橋和宏, 伊藤浩, 竹之下誠一
    • Organizer
      第58回日本核医学会学術総会
    • Related Report
      2018 Annual Research Report
  • [Presentation] [211At]MABGの自動合成装置を用いた製造と品質評価2018

    • Author(s)
      粟生木美穂, 峯岸克行, 鈴木寿, 小田敬, 佐々木茂範, 鷲山幸信, 西嶋剣一, 永津弘太郎, 張明栄, 高橋和宏
    • Organizer
      第58回日本核医学会学術総会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 短寿命α線核種の飛散率等の基礎データ取得と合理的法規制に向けた安全性検証と放射線管理法の開発2018

    • Author(s)
      短寿命α線核種の飛散率等の基礎データ取得と合理的法規制に向けた安全性検証と放射線管理法の開発, 篠原厚, 豊嶋厚史, 吉村崇, 兼田加珠子, 張子見, 永田光知郎, 渡部直史, 畑澤順, 大江一弘, 山村朝雄, 白崎謙次, 菊永英寿, 羽場宏光, 鷲山幸信
    • Organizer
      日本放射線安全管理学会 第17回学術大会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 短寿命アルファ線放出核種At-211の合理的規制に向けた飛散率測定2018

    • Author(s)
      豊嶋厚史, 篠原厚, 吉村崇, 兼田加珠子, 張子見, 永田光知郎, 渡部直史, 大江一弘, 山村朝雄, 白崎謙次, 菊永英寿, 羽場宏光, 鷲山幸信
    • Organizer
      日本放射線安全管理学会 第17回学術大会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 動物実験における短寿命アルファ線核種の体内外の分布2018

    • Author(s)
      篠原厚,吉村崇, 豊嶋厚史, 兼田(中島)加珠子, 張子見, 永田光知郎, 渡部直史, 大江一弘, 山村朝雄、 白崎謙次, 菊永英寿, 羽場宏光, 鷲山幸信
    • Organizer
      日本放射線安全管理学会 第17回学術大会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 合理的規制のためのラジウム-223およびその子孫核種の飛散率等の測定2018

    • Author(s)
      永田光知郎, 吉村崇, 豊嶋厚史, 篠原厚, 兼田加珠子, 張子見, 渡部直史, 大江一弘, 山村朝雄, 白崎謙次, 菊永英寿, 羽場宏光, 鷲山幸信
    • Organizer
      日本放射線安全管理学会 第17回学術大会
    • Related Report
      2018 Annual Research Report
  • [Presentation] Is it possible to detect the contamination of At-211 using survey meter ?2018

    • Author(s)
      Kubo H, Shimoyama S, Ukon N, Zhao S, Ito H, Takahashi K, Aoki M, Washiyama K, Nishijima K, Sasaki S, Yabuki S
    • Organizer
      第58回日本核医学会学術総会
    • Related Report
      2018 Annual Research Report
  • [Presentation] Evaluation of the distribution of At-211 solution dispersion in the small animal cage2018

    • Author(s)
      Kubo H, Shimoyama S, Ukon N, Zhao S, Ito H, Takahashi K, Aoki M, Washiyama K, Nishijima K, Sasaki S, Yabuki S
    • Organizer
      第58回日本核医学会学術総会
    • Related Report
      2018 Annual Research Report
  • [Presentation] ペプチドの At-211標識法の開発と基礎的評価2018

    • Author(s)
      武田拓也, 小川数馬, 三代憲司, 豊嶋厚史, 吉村崇, 篠原厚, 柴和弘, 絹谷清剛, 小谷明
    • Organizer
      日本薬学会第138年会
    • Related Report
      2017 Annual Research Report
  • [Presentation] Targeted α-based treatment with Ra-223 for metastatic castration-resistant prostate cancer.2017

    • Author(s)
      Matsuo S, Wakabayashi H, Hiromasa T, Akatani N, Watanabe S, Nakajima K, Kinuya S.
    • Organizer
      Asia Oceania Congress of Nuclear Medicine and Biology
    • Related Report
      2017 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Dosimetry of t Ra-223 treatment for metastatic castration-resistant prostate cancer2017

    • Author(s)
      Matsuo S, Kinuya S, Mizomami A, Nakajima K, Wakabayashi H, Kudo T
    • Organizer
      EANM'17 - Annual Meeting of European Association of Nuclear Medicine
    • Related Report
      2017 Annual Research Report
    • Int'l Joint Research
  • [Presentation] α線内用療法を目指した標識ペプチドの合成と基礎的評価2017

    • Author(s)
      武田拓也, 小川数馬, 三代憲司, 豊嶋厚史, 吉村崇, 篠原厚, 柴和弘, 絹谷清剛, 小谷明
    • Organizer
      日本薬学会北陸支部第129回例会
    • Related Report
      2017 Annual Research Report
  • [Presentation] At-211標識RGDペプチドの基礎的検討2017

    • Author(s)
      武田拓也, 小川数馬, 三代憲司, 豊嶋厚史, 吉村崇, 篠原厚, 柴和弘, 絹谷清剛, 小谷明
    • Organizer
      第17回放射性医薬品・画像診断薬研究会
    • Related Report
      2017 Annual Research Report
  • [Presentation] Utilization of radionuclides in nuclear medicine2017

    • Author(s)
      Kinuya S
    • Organizer
      Seminar Nasional Pendyagunaan Teknologi Nuklir (SENPATEN)
    • Related Report
      2017 Annual Research Report
    • Int'l Joint Research / Invited
  • [Presentation] Strategies for the future of nuclear medicine2017

    • Author(s)
      Kinuya S
    • Organizer
      Asia Oceania Congress of Nuclear Medicine and Biology
    • Related Report
      2017 Annual Research Report
    • Int'l Joint Research / Invited
  • [Presentation] Concept of targeted radionuclide therapy: For the future of interdisciplinary collaboration2017

    • Author(s)
      Kinuya S
    • Organizer
      Translational Immunology - from target to therapy IV
    • Related Report
      2017 Annual Research Report
    • Int'l Joint Research / Invited
  • [Presentation] Recent researches on targeted radionuclide therapy in Japan2016

    • Author(s)
      Seigo Kinuya
    • Organizer
      1st International Conference on Molecular Imaging
    • Place of Presentation
      Xiamen, China
    • Year and Date
      2016-12-09
    • Related Report
      2016 Annual Research Report
    • Int'l Joint Research / Invited
  • [Presentation] 我が国におけるRI内用療法の現状と将来2016

    • Author(s)
      絹谷清剛
    • Organizer
      第54回日本癌治療学会学術集会
    • Place of Presentation
      横浜市
    • Year and Date
      2016-10-20
    • Related Report
      2016 Annual Research Report
    • Invited
  • [Presentation] Present status and strategy to develop targeted radionulcide therapy in Japan2016

    • Author(s)
      Seigo Kinuya
    • Organizer
      Asia Regional Cooperative Council of Nuclear Medicine
    • Place of Presentation
      Shenyang, China
    • Year and Date
      2016-07-14
    • Related Report
      2016 Annual Research Report
    • Int'l Joint Research / Invited

URL: 

Published: 2016-04-21   Modified: 2020-03-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi